According to the mainstream literature, CD44+/CD24− has been designated as CSC marker of breast cancer, including T47D and MCF-7;30,31 however, a few other studies suggested CD44+/CD24+ subpopulation also display CSC-like properties32. Here, CD24 is linked to breast carcinoma.